Equity
€567,730 ▲ 104%
Equity rose in 2025 from €278,631 to €567,730.
NHUMEDICS
Lifetime
3 annual accounts with figures on one time axispeak €381,223 (2025)
€381,223▲ 55.3%
peak €289,099 (2025)
€289,099▲ 54.6%
peak €567,730 (2025)
€567,730▲ 104%
€96,461▲ 51.2%
Board1 name since 2023
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Gross margin from €245,435 to €381,223Result from €187,010 to €289,099Equity from €278,631 to €567,730Debts from €63,778 to €96,461Investments €5,213Cash from €129,075 to €240,799
Key points
from the 2025 annual accountsTurnover
≈ €770,000 estimated
The micro format states no turnover.
Investments
€5,213 3.5 × depreciation
Green is investment, beige is depreciation.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,135 companies had the same profile as NHUMEDICS has now. Each dot stands for 8 companies, two years later.
97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,135 companies, not a prediction for NHUMEDICS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0803970345
Incorporation
Founding capital of €3,000, 30 shares · Founder: · Appointment: (director) · published on 18-07-2023 · Gazette deed
First establishment
Pastoor Paquaylaan 129, Heusden-Zolder
Official details
Source: KBO- Status
- Active since 14-07-2023Normal situation
- Activity
- “De uitoefening van de geneeskunde, meer bepaald radiologie door de arts-aandeelhouder in naam en…” (deed in Dutch)From the articles, 8 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.347.426.3283550 Heusden-Zolder, since 14-07-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 05-11-2024
Annual accounts 2025
- €664,192▲ 94.0%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on NHUMEDICS
NHUMEDICS files the micro format. That format states no turnover. The gross margin rose from €124,243 in 2023 to €381,223 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NHUMEDICS
- What is the company number of NHUMEDICS?
- The company number of NHUMEDICS is 0803.970.345. The VAT number is the same number with BE in front: BE 0803.970.345.
- Where is NHUMEDICS based?
- The registered office is at Beurtstraat 91, 3390 Tielt-Winge.Company details
- What is the legal form of NHUMEDICS?
- NHUMEDICS is a private limited company (BV).
- When was NHUMEDICS founded?
- NHUMEDICS was founded on 14-07-2023.
- Is NHUMEDICS still active?
- Yes, NHUMEDICS is an active enterprise in the KBO register.
- What is the turnover of NHUMEDICS?
- The turnover in financial year 2025 is ≈ €770,000. This figure is estimated from the gross margin of €381,223 and 1,019 comparable companies of the same size. It probably lies between €530,000 and €1.1m. It is a rough estimate.Financials
- Is NHUMEDICS profitable?
- In financial year 2025, NHUMEDICS made a profit of €289,099.
- Where can I find the annual accounts of NHUMEDICS?
- NHUMEDICS filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NHUMEDICS due?
- NHUMEDICS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.